Medicenna Therapeutics

Toronto, Canada

Medicenna is a clinical stage, privately held, immuno-oncology company.

$4.4M raised

Jun 2026

Post-IPO Equity

Biotechnology Health Care Medical Oncology Therapeutics

Top Investors

RA Capital ManagementCancer Prevention and Research Institute of Texas

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Medicenna Therapeutics

How much funding has Medicenna Therapeutics raised?

Medicenna Therapeutics has raised $4.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.

Who are Medicenna Therapeutics's investors?

Medicenna Therapeutics's investors include RA Capital Management, Cancer Prevention and Research Institute of Texas.

Where is Medicenna Therapeutics headquartered?

Medicenna Therapeutics is headquartered in Toronto, Canada.

What does Medicenna Therapeutics do?

Medicenna is a clinical stage, privately held, immuno-oncology company.

What stage is Medicenna Therapeutics at?

Medicenna Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 26, 2026.

MLA

"Medicenna Therapeutics — Funding & Investors." VCBacked, June 26, 2026, https://www.vcbacked.co/company/medicenna-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Medicenna Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/medicenna-therapeutics

Wikipedia (cite web)

{{cite web |title=Medicenna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/medicenna-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 26, 2026.